본문 바로가기
KERD
논문KCI 등재

아밀로이드 영상 양성인 알츠하이머병에서의 렘수면행동장애 유병률 연구

The Prevalence of Rapid Eye Movement Sleep Behavior Disorder in Amyloid Positron Emission Tomography Positive Alzheimer’s Disease

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Objectives: Rapid eye movement (REM) sleep behavior disorder (RBD) is well known as a prodromal symptom of neurodegenerative disease, especially α-synucleinopathy. In the previous literature, it has been reported the incidence rate of RBD in Alzheimer’s disease (AD) is about 10%. This incidence rate is relatively low, if we consider that nearly half of AD patients also have Lewy body pathology. The objective of this study is to determine the incidence rate of RBD among patients with AD, confirmed by amyloid positron emission tomography (PET) image. Methods: We enrolled 57 patients with clinically probable AD patients who identified AD pathology in amyloid PET scan. RBD was evaluated with REM sleep behavior disorder questionnaire-Korean vesion (RBDQ-KR), which validated the RBD screening questionnaire as Korean version to confirm RBD. Detailed neuropsychological tests were measured using the Seoul Neuropsychological Screening Battery (SNSB). Results: We analyzed RBDQ-KR data collected from 57 AD patients. Dementia due to AD was 36 patients (63.2%) and mild cognitive impairment (MCI) due to AD was 21 (36.8%). AD with RBD was 14 (24.6%). Among these, AD dementia with RBD was 13 (36.1%), and MCI due to AD with RBD was 1 (4.8%). There were no significant differences in cognitive function between the patients with or without RBD, evaluated by detailed neuropsychological test. Conclusions: In this study, the incidence of RBD in AD was not rare; therefore, if the patient shows symptoms of RBD, we should not rule out AD.

Abstract

Objectives: Rapid eye movement (REM) sleep behavior disorder (RBD) is well known as a prodromal symptom of neurodegenerative disease, especially α-synucleinopathy. In the previous literature, it has been reported the incidence rate of RBD in Alzheimer’s disease (AD) is about 10%. This incidence rate is relatively low, if we consider that nearly half of AD patients also have Lewy body pathology. The objective of this study is to determine the incidence rate of RBD among patients with AD, confirmed by amyloid positron emission tomography (PET) image. Methods: We enrolled 57 patients with clinically probable AD patients who identified AD pathology in amyloid PET scan. RBD was evaluated with REM sleep behavior disorder questionnaire-Korean vesion (RBDQ-KR), which validated the RBD screening questionnaire as Korean version to confirm RBD. Detailed neuropsychological tests were measured using the Seoul Neuropsychological Screening Battery (SNSB). Results: We analyzed RBDQ-KR data collected from 57 AD patients. Dementia due to AD was 36 patients (63.2%) and mild cognitive impairment (MCI) due to AD was 21 (36.8%). AD with RBD was 14 (24.6%). Among these, AD dementia with RBD was 13 (36.1%), and MCI due to AD with RBD was 1 (4.8%). There were no significant differences in cognitive function between the patients with or without RBD, evaluated by detailed neuropsychological test. Conclusions: In this study, the incidence of RBD in AD was not rare; therefore, if the patient shows symptoms of RBD, we should not rule out AD.

참고문헌 (44)

  1. Schenck CH, "Chronic behavioral disorders of human REM sleep : a new category of parasomnia", Sleep, 9, pp.293~308 (1986)
  2. Kang SH, "REM sleep behavior disorder in the Korean elderly population : prevalence and clinical characteristics", Sleep, 36, pp.1147~1152 (2013)
  3. Haba-Rubio J, "Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population", Sleep, 41, pp.pii: zsx19~ (2018)
  4. Boeve BF, "REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions", Ann N Y Acad Sci, 1184, pp.15~54 (2010)
  5. Plazzi G, "REM sleep behavior disorders in multiple system atrophy", Neurology, 48, pp.1094~1097 (1997)
  6. Gagnon JF, "REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease", Neurology, 59, pp.585~589 (2002)
  7. Boeve BF, "REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies", J Geriatr Psychiatry Neurol, 17, pp.146~157 (2004)
  8. Plomhause L, "Rapid eye movement sleep behavior disorder in treatment-naïve Parkinson disease patients", Sleep Med, 14, pp.1035~1037 (2013)
  9. Poryazova R, "REM sleep behavior disorder in Parkinson’s disease : a questionnaire-based survey", J Clin Sleep Med, 9, pp.55~59 (2013)[DOI]
  10. Boeve BF, "Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism", Neurology, 61, pp.40~45 (2003)
  11. Ferman TJ, "Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies", Neurology, 77, pp.875~882 (2011)
  12. Galbiati A, "REM sleep behavior disorder and Alzheimer’s disease: definitely no relationship?", J Alzheimers Dis, 63, pp.1~11 (2018)
  13. Popescu A, "Lewy bodies in the amygdala : increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions", Arch Neurol, 61, pp.1915~1919 (2004)
  14. Hamilton RL, "Lewy bodies in Alzheimer’s disease : a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry", Brain Pathol, 10, pp.378~384 (2000)
  15. Lippa CF, "Antibodies to alphasynuclein detect Lewy bodies in many Down’s syndrome brains with Alzheimer’s disease", Ann Neurol, 45, pp.353~357 (1999)
  16. Arai Y, "Alpha-synuclein-positive structures in cases with sporadic Alzheimer’s disease : morphology and its relationship to tau aggregation", Brain Res, 888, pp.287~296 (2001)
  17. Korff A, "α-synuclein in cerebrospinal fluid of Alzheimer’s disease and mild cognitive impairment", J Alzheimers Dis, 36, pp.679~688 (2013)
  18. Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.270~279 (2011)
  19. McKhann GM, "The diagnosis of dementia due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.263~269 (2011)
  20. You S, "The REM sleep behavior disorder screening questionnaire : validation study of the Korean version(RBDQ-KR)", J Clin Sleep Med, 13, pp.1429~1433 (2017)
  21. Park JH, "Modification of the mini‐mental state examination for use in the elderly in a non‐western society. Part 1. Development of Korean version of mini‐mental state examination", Int J Geriatr Psychiatry, 5, pp.381~387 (1990)
  22. Reisberg B, "The global deterioration scale for assessment of primary degenerative dementia", Am J Psychiatry, 139, pp.1136~1139 (1982)
  23. Hughes CP, "A new clinical scale for the staging of dementia", Br J Psychiatry, 140, pp.566~572 (1982)
  24. Lee SA, "The utility of a Korean version of the REM sleep behavior disorder screening questionnaire in patients with obstructive sleep apnea", J Neurol Sci, 358, pp.328~332 (2015)
  25. 김수영, "한국어판 바텔 일상활동 지표(Bathel ADL Index)의 개발", Korean Journal of Family Medicine, 25(7), pp.534~541 (2004), 대한가정의학회
  26. Kang Y, "Seoul neuropsychological screening battery(SNSB)" (2003), Human Brain Research & Consulting Co
  27. Li SX, "Validation of a new REM sleep behavior disorder questionnaire(RBDQ-HK)", Sleep Med, 11, pp.43~48 (2010)
  28. 강수진, "한국판 Instrumental Activities of Dalily Living의 타당도와 신뢰도", 대한신경과학회지, 20(1), pp.8~14 (2002), 대한신경과학회
  29. Knopman DS, "Practice parameter:diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology", Neurology, 56, pp.1143~1153 (2001)
  30. Jack CR Jr, "NIA-AA research framework : toward a biological definition of Alzheimer’s disease", Alzheimers Dement, 14, pp.535~562 (2018)
  31. Curtis C, "Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density", JAMA Neurol, 72, pp.287~294 (2015)
  32. Sabri O, "Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer’s disease : phase 3 study", Alzheimers Dement, 11, pp.964~974 (2015)
  33. Clark CM, "Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study", Lancet Neurol, 11, pp.669~678 (2012)
  34. Stiasny-Kolster K, "The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument", Mov Disord, 22, pp.2386~2393 (2007)
  35. Boeve BF, "Validation of the Mayo sleep questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort", Sleep Med, 12, pp.445~453 (2011)
  36. Boeve BF, "Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease", Brain, 130, pp.2770~2788 (2007)
  37. Braak H, "Staging of brain pathology related to sporadic Parkinson’s disease", Neurobiol Aging, 24, pp.197~211 (2003)
  38. Wang P, "Rapid eye movement sleep behavior disorder in patients with probable Alzheimer’s disease", Aging Clin Exp Res, 28, pp.951~957 (2016)
  39. Postuma RB, "Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder", Neurology, 72, pp.1296~1300 (2009)
  40. Wing YK, "Prospective outcome of rapid eye movement sleep behaviour disorder : psychiatric disorders as a potential early marker of Parkinson’s disease", J Neurol Neurosurg Psychiatry, 83, pp.470~472 (2012)
  41. Kim HJ, "Brain atrophy of secondary REM-sleep behavior disorder in neurodegenerative disease", J Alzheimers Dis, 52, pp.1101~1109 (2016)
  42. Samuel W, "Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density", J Neuropathol Exp Neurol, 56, pp.499~508 (1997)
  43. Stern Y, "An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease", Arch Neurol, 58, pp.460~465 (2001)
  44. Tsuang D, "APOE ε4 increases risk for dementia in pure synucleinopathies", JAMA Neurol, 70, pp.223~228 (2013)

관련 논문AI추천

이 간행물의 다른 논문 (9건)